By the Top Tier Newswire AI Desk · July 27, 2026 at 12:17 AM ET · reviewed against 1 wire stories
IMMUNITYBIO INC (IBRX) is drawing unusual attention today. Our newswire has captured 1 story on IBRX across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 58/100).
Why IBRX stock is moving today
ImmunityBio Inc (IBRX) stock is moving higher today, with the stock rising after a period of quiet trading in July. Retail traders are showing heightened interest ahead of a biotech conference, with some observers interpreting the lack of news as a sign of strategic buildup. Recent insider sales and a subdued 30-day sentiment trend have not dampened speculative interest, particularly as the stock remains within its 52-week range of $1.95 to $12.43.
What Happened
Retail traders on Stocktwits have been closely watching ImmunityBio's activity, with some suggesting the recent quiet period may indicate a larger move before an upcoming biotech conference. The company has been in the news for presenting data at the American Society of Clinical Oncology Annual Meeting regarding its Phase 3 studies in advanced non-small cell lung cancer. Additionally, HC Wainwright & Co. recently reiterated a Buy rating on the stock with a $15 price target. These developments have contributed to the renewed attention on the stock, even as the company remains unprofitable with an EPS of -0.89 for the trailing twelve months.
What The Data Shows
Over the past eight trading sessions, the stock has declined 8.2% from $7.73 to $7.10. Insider transactions over the last 90 days include five sales totaling $3.9 million, with the most recent filing on July 6. The stock’s beta of 0.08 indicates low volatility relative to the market, and its revenue has grown by 351.5% in the trailing twelve months. Despite this, the stock has seen no social media chatter in the last 24 hours and only two posts in the past week.
What To Watch
Investors should monitor upcoming corporate developments and potential news from the biotech conference for any catalysts that may influence the stock’s direction.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
IBRX · Jul 27 session (5-min) · -1.13% vs prior close · updated 8:56 PM ETAI sentiment, last 36h · averaged over 1 story · 58/100 bullish
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
3d agoStocktwits NewsBULLISH 58General
IBRX Stock Rises Overnight: Retail Traders Hunt For Global Expansion Clues Ahead Of Biotech Conference
Weekend chatter focused on ImmunityBio’s quiet July, with some bulls calling the silence the “quiet before the kraken.”
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →